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Squamous cell carcinoma accounts for 20% of all human lung
cancers and is strongly linked to cigarette smoking. It develops
through premalignant changes that are characterized by high
levels of keratin 14 (K14) expression in the airway epithelium
and evolve through basal cell hyperplasia, squamous metaplasia
and dysplasia to carcinoma in situ and invasive carcinoma. In
order to explore the impact of K14 in the pulmonary epithelium
that normally lacks both squamous differentiation and K14 ex-
pression, human keratin 14 gene hK14 was constitutively ex-
pressed in mouse airway progenitor cells using a mouse Clara
cell speciﬁc 10 kDa protein (CC10) promoter. While the lungs of
CC10-hK14 transgenic mice developed normally, we detected in-
creased expression of K14 and the molecular markers of squa-
mous differentiation program such as involucrin, loricrin, small
proline-rich protein 1A, transglutaminase 1 and cholesterol sulfo-
transferase 2B1. In contrast, wild-type lungs were negative. Aging
CC10-hK14 mice revealed multifocal airway cell hyperplasia, oc-
casional squamous metaplasia and their lung tumors displayed
evidence for multidirectional differentiation. We conclude that
constitutive expression of hK14 initiates squamous differentiation
program in the mouse lung, but fails to promote squamous
maturation. Our study provides a novel model for assessing the
mechanisms of premalignant lesions in vivo by modifying differ-
entiation and proliferation of airway progenitor cells.
Introduction
Squamous cell carcinoma (SQCA) of the lung accounts for 20% of
human lung cancers in the USA and is strongly linked with cigarette
smoking. Lung SQCA and its precursor lesions express high levels of
keratin 14 (K14) (1,2). In many epithelia, including that of skin,
esophagus and tongue, squamous differentiation represents a normal
pathway of differentiation, whereas in other tissues, including the
epithelial lining of conducting airways, it occurs under pathological
conditions (3). Morphologic and biochemical studies have indicated
that squamous differentiation is a multistage process and involves the
sequential expression of many speciﬁc genes including keratins (3,4).
Keratins form a cytoplasmic network of 10–12 nm wide interme-
diate ﬁlaments and are classiﬁed into acidic type I keratins K9–K23
and basic type II keratins K1–K8 (5). They occur as heterodimers,
whose expression is dependent on the type of the epithelium. K14 is
an epidermal keratin, which is paired with keratin 5 (K5) and located
in the proliferating basal cell layer of stratiﬁed squamous epithelia.
On the other hand, K8 and 18 are the keratins in non-cutaneous,
single-layered epithelium including normal airways (1,5). There is
emerging evidence that cytokeratins are important scaffolding pro-
teins that may impact many cellular functions ranging from cell sig-
naling to proliferation and apoptosis in addition to their more
traditional role in structural support (6,7).
SQCA is the only human lung cancer type, whose premalignant
lesions are well characterized (8–10). It is thought to develop from
K14-positive basal cells through hyperplasia, squamous metaplasia
and dysplasia to in situ and invasive carcinoma, whereas normal
airway epithelium lacks any signs of squamous differentiation. In
mouse lung, SQCA and K14-containing cells are exceedingly rare
(supplementary Figure 1s is available at Carcinogenesis Online). In
order to explore the role of K14 expression in pulmonary epithelium
that normally lacks both squamous differentiation and K14 expres-
sion, human keratin 14 gene hK14 was constitutively expressed
in mouse lung using a Clara cell speciﬁc 10 kDa protein (CC10)
promoter.
We postulated that mice rarely develop pulmonary SQCA because
of the lack or relative sparsity of K14 in the airways. Here, we show
evidence that constitutive expression of hK14 initiates squamous dif-
ferentiation pathway in CC10-hK14 transgenic (TG) mouse lung as
evidenced by the expression of squamous differentiation markers of
the corniﬁed cell envelope (CCE) formation (11,12). TG animals
displayed multifocal airway cell hyperplasia, squamous metaplasia
and lung tumors with increasing age. While there was no histological
evidence for overt squamous maturation, tumors displayed immuno-
histochemical evidence for multidirectional differentiation, suggest-
ing that hK14 modulates divergent pathways in the lung.
Materials and methods
Preparation of hK14 construct
We cloned hK14 from human epidermal keratinocytes (ScienceCell Research
Laboratories, San Diego, CA) by polymerase chain reaction (PCR) using high-
ﬁdelity enzyme pfu (Stratagene, La Jolla, CA; supplementary Figure 2s is
available at Carcinogenesis Online). The hK14 fragment (1.4 kb) was cloned
into pcDNA3.1 (Invitrogen, San Diego, CA) and into 0.8 and 2.1 kb of up-
stream 5#-ﬂanking sequences of the mouse Clara cell 10 kDa protein (mCC10)
promoter (13). The promoter was a gift from Dr Francisco DeMayo, Baylor
College of Medicine, Houston,TX. An XbaI fragmentcontaining the transgene
was gel puriﬁed using Qiaex (Qiagen, Valencia, CA) resin and eluted into 60 ll
of modiﬁed Tris–ethylenediaminetetraacetic acid.
Cell lines and transfection experiments
The human immortalized normal bronchial epithelial BEAS-2B and lung ad-
enocarcinoma (NCI-H441) cell lines were obtained from American Type
Culture Collection (Manassas, VA) and propagated in BEGM (Lonza,
Walkersville, MD) and RPMI (Invitrogen), respectively. Transient transfec-
tions using liposome technique were carried out with a total of 5 lgD N A
per well for six-well plates for 16 h.
Animals and genotyping
The CC10-hK14 transgene was microinjected into one-cell fertilized FVB/N
mouse embryos at a concentration of 2 ng/ll as described previously (14). All
animals were housed and handled in a human manner following the guide-
lines by an National Cancer Institute Animal Care and Use Committee
Abbreviations: CCE, corniﬁed cell envelope; CC10, Clara cell speciﬁc 10 kDa
protein; hK14, human keratin 14; IHC, immunohistochemistry; mCC10, mouse
Clara cell 10 kDa protein; mRNA, messenger RNA; PCR, polymerase chain
reaction; Q-RT–PCR, quantitative reverse transcription polymerase chain re-
action; SQCA, squamous cell carcinoma; TG, transgenic; WT, wild-type.
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ﬁrmed by Southern blot analysis of 10 lg of tail DNA digested with BamHI
(15) and was probed with CC10-hK14 fragment labeled with 32P by random
priming with (32P)dCTP (ICN, Irvine, CA) (16). The hybridization condi-
tions were as described by Church et al. (17). TG pups were identiﬁed using
a PCR analysis of tail biopsies taken after weaning. DNAwas extracted from
the specimens using Red-Extract (Sigma–Aldrich, St Louis, MO). The strategy
and primers are illustrated in Figure 1C and Table I, respectively. Samples were
ampliﬁed following denaturation at 94C for 2 min by 40 cycles of denaturation
at 94C for 30 s, annealing at 55C for 1 min and extension at 72Cf o r1m i n ,
with a ﬁnal extension of 72C (Bio-Rad iCycler, Hercules, VA).
RNA isolation and quantitative reverse transcription poymerase chain reaction
analysis
Total RNAwas isolated from cell lines and mouse tissue using RNeasy Mini
Kit (Qiagen) according to the manufacturer’s protocol. For real time PCR,
complementary DNAwas initially generated from 1.5 lg of RNA (previously
treated by DNAase-I from Roche Diagnostics, Indianapolis, IN) extracted
from cell lines, lungs and tracheas, using Script cDNA Synthesis Kit (Am-
bion, Austin, TX). PCR conditions for keratins and CCE proteins (Table I)
were as follows: 95C for 5 min, 25 cycles at 95C for 1 min, 58Cf o r1m i n
and 72C for 1 min, with an extension step of 7 min at 72C at the end of the
last cycle. For quantitative reverse transcription polymerase chain reaction
(Q-RT–PCR), QuantiTect SYBR Green PCR Kit (Qiagen) and PCR ampli-
ﬁcation in MyiQ (Bio-Rad, Richmond, CA) were used according to the pro-
tocol provided by the manufacturer. Conditions for PCR included 50Cf o r
2m i n ,9 5 C for 15 min and 45 cycles of 95C for 30 s and 60C for 30 s. Each
reaction was run in triplicate in a 96-well plate. Relative expression of the target
gene was calculated using the 2DCT method described previously (18). Relative
expression 5 2DCT,w h e r eDCT 5 CT(target gene)CT(endogenous control gene)
where mouse ribosomal 15 and 18 (S15, S18) were used as the endogenous
control gene.
Western blot analysis and immunoprecipitation
Cells and tissues were washed twice with phosphate-buffered saline and lysed
in radio-immuno precipitation assay (RIPA) buffer. Protein concentration was
Fig. 1. Generation of CC10-hK14 TG mice. (A) hK14 complementary DNAwas cloned into a plasmid that contains a 2.1 kb mouse CC10 (mCC10) promoter,
b-globin intron as enhancer and bovine growth hormone (bGH) polyA. Sequencing was done using T7 and T3 primers. (B) Southern blot analysis of CC10-hK14
TG mouse founders. Lanes J7, E10, E9, F8 and F7 revealed the expected band size (2.1 kb) for hK14 transgene. The positive control (lane C) included a mixture of
plasmid DNA (CC10-hK14) of transgene and WT tail DNA digested with BamHI. Results composed of three separate gels (1–3). (C) Genotyping of CC10-hK14
TG mice by PCR.Two sets of primerswere used as indicatedin a schematicillustration (top). Ampliﬁcation of both fragmentsof tail DNA in lanes B, C, E–G, J–O
and R indicated the contiguity of the incorporated transgene. First and last lanes (M) correspond to molecular markers.
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2378determined using Bio-Rad DC protein assay with bovine immunoglobin G as
the standard. Proteins were separated by sodium dodecyl sulfate–polyacryl-
amide gel electrophoresis (Bio-Rad) and transferred to an Immobilon-P mem-
brane (Millipore, Bedford, MA). Anti-K14 polyclonal antibody (The Binding
Site, SanDiego, CA)wasused atdilutionof1:500. Internalexpressioncontrols
were done by using b-actin (Sigma-Aldrich). The protein expression of the
hK14 transgene in mouse tissues was determined by immunoprecipitation.
Tissue lysates were incubated overnight with the mouse anti-hK14 antibody
(Clone 4A30; US-Biological, Swampscott, MA) and then precipitated with
protein G-agarose beads (Pierce, Rockford, IL) as described previously
(19,20). Washed immunoprecipitates were resolved by sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis and visualized on nitrocellulose using
streptavidin-peroxidase method and enhanced chemiluminescence.
Morphology and immunohistochemistry
Formorphologic analyses,micewere serially killedat 1–2,3–4, 6–7,14 and 21
months of age, a minimum of ﬁve mice in each group. Dissected lungs were
ﬁxed in 4% buffered paraformaldehyde and embedded in parafﬁn.
Immunohistochemistry (IHC) was performed using avidin-biotinylated perox-
idase method (21) and polyclonal anti-murine CC10 (1:10 000; a gift from Dr
Francesco DeMayo, Baylor School of Medicine, Houston, TX), human pro-
surfactant protein C (proSP-C; 1:100, Chemicon International, Temecula, CA),
involucrin and loricrin (1:500 each, Covance, San Diego, CA), K14, K8 and
K18 (1:100 each, The Binding Site) and monoclonal anti-p63 (Clone 4A4;
1:500, Santa Cruz Biotechnology, Santa Cruz, CA) and cytokeratin (34bE12
cocktail; 1:100, Dako, Carpinteria,CA), which recognizes cytokeratins 1, 5, 10
and 14. Staining was analyzed with a Nikon Eclipse 400 microscope and
Metamorph software (Molecular Devices Corporation, Downingtown, PA).
Statistical analysis
Statistical analysis of data was carried by using SigmaStat3.5 software (Aspire
Software International, Ashburn, VA). Mann–Whitney rank-sum and chi-
square tests were used for analysis and a P value of 0.05 or less was considered
to be signiﬁcant.
Results
Cloning of hK14 and generation of CC10-hK14 TG mice
The hK14 gene was ﬁrst cloned into an expression vector containing
cytomegalovirus (CMV) in pcDNA3.1. In order to direct the expres-
sion of hK14 to airway epithelial cells, we prepared two different size
constructs (0.8 and 2.1 kb) of mCC10 promoter (Figure 1A).
To conﬁrm the functional expression of the cloned gene, we per-
formed in vitro transfections using COS-7 and the human lung ade-
nocarcinoma H441 cells. Using two different liposomal agents and
CMV in pcDNA3.1, the 50 kDa hK14 was expressed at similar in-
tensity. No expression was seen in untransfected parent COS-7 cells.
Both 0.8 and 2.1 kb mCC10 promoters and CMV in pcDNA3.1 also
resulted in hK14 expression at similar intensities in H441 cell line,
which originally was negative (data not shown). The immortalized
normal human bronchial epithelial cells BEAS-2B were used as pos-
itive control because of their endogenous expression of hK14 protein.
TG mice were generated using hK14 gene fused to 2.1 kb of
mCC10 5#-ﬂanking DNA by standard methods. Several independent
positive founders were obtained. Figure 1B shows a representative
Southern blot analysis of tail DNA from 11 mice. Total DNA was
digested with BamHI. A diagnostic 2.1 kb band was detected in mice
J7, E10, E9, F8 and F7 migrating at the same level as the puriﬁed
BamHI CC10 DNA fragment, which was used as probe. The 5.3 kb
band in the gel represents a partial digest. The positive control for
Southern blot included a mixture of plasmid DNA (transgene) and
wild-type (WT) tail DNA, digested with the same enzyme BamHI
(lane C). The diagnostic fragment was not detected in other mice
(lanes J8, F1, F9, F6, F5 and F4). Mice J7, E10, E9, F8 and F7 were
used as founders, which were outbred to establish breeding lines. The
founders and ﬁrst generation mice were followed up till 21 months.
The PCR-based genotyping strategy is illustrated in Figure 1C. In
order to ensure the contiguity of the transgene that was incorporated
into the mouse genome, we used two sets of primers (Table I) cover-
ing a 750 bp segment of the mCC10 promoter (PCR-1) as well as
a 650 bp segment of the hK14 gene (PCR-2). A representative gel
(Figure 1C) demonstrates that there was contiguity of the transgene in
12 mice with similar expression levels following each PCR, thus
conﬁrming the incorporation. In eight of them there was strong ex-
pression (lanes B, C, E, F, G, J, L and N), whereas four of the mice
showed weaker bands (lanes K, M, O and R).
Table I. Sequences of the primers
PCR systems mRNA Primer name Sequences (5#–3#)
Conventional PCR Mouse Clara cell speciﬁc 10 kDa protein CC10-F CAGGTACTCAAGGGCTGCTC
Mouse b globin intron bG-R GGGTCCATGGTGATACAAGG
bG-F GGGTGTTGTGCTGTCTCATC
Human K14 K14-R1 ATCTGCAGAAGGACATTGGC
K14-F2 AGGTGACCATGCAGAACCTC
K14-R2 GTCCACTGTGGCTGTGAGAA
Mouse K14 K14-F1 CTGGTGGGCAGTGAGAAAGT
K14-R1 CCAGGATCTTGCTCTTCAGG
T7 promoter T7 TAATACGACTCACTATAGGG
T3 promoter T3 ATTAACCCTCACTAAAG
Real-time PCR Human K14 K14-F3 TGAGAAGGTGACCATGCAGA
K14-R3 ATTGTCCACTGTGGCTGTGA
Mouse K14 K14-F2 CAGCCCCTACTTCAAGACCA
K14-R2 GGCTCTCAATCTGCATCTCC
Mouse involucrin INV-F CAGAACTGCCTCTGGGAAAG
INV-R GGGTCAGGTGACTCCTGGTA
Mouse loricrin LOR-F TCCTATGGAGGTGGTTCCAG
LOR-R CCACCTCCGGAGTACTTGAC
Mouse small proline-rich-protein 1A (SPRR 1A) SPRR-F ATGAGTTCCCACCAGCAGAA
SPRR-R AGGCTCTGGTGCCTTAGGTT
Mouse cholestrol sulfotransferase 2B1 (SULT2B1) SULT2B1-F TACACCCGACCAGTTCCTTC
SULT2B1-R CAGCAGCGAGTAGTTGGACA
Mouse transglutaminase 1 (TGase 1) TGase 1-F GACTGGCGGCAAGAATATGT
TGase 1-R TGAGCAGGATCTCCACACTG
Mouse ribosomal S15 S15-F TTCCGCAAGTTCACCTACC
S15-R CGGGCCGGCCATGCTTTACG
Mouse ribosomal S18 S18-F TCCCATCCTTCACATCCTTC
S18-R TGTGGTGTTGAGGAAAGCAG
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The CC10-hK14 TG mice were breeding without difﬁculty. Grossly,
lungs of TG mice appeared normal. Microscopic and ultrastructural
(data not shown) examination failed to reveal signiﬁcant abnormali-
ties in younger animals. Clara cells in TG mice retained their hobnail
appearance. However, the airway epithelium in older mice (6–21
months) showed multifocal hyperplasia and occasional squamous
metaplasia (Figure 2A–D). By IHC, the lungs of WT littermates were
consistently negative for K14, whereas the expression in older TG
mice revealed several patterns including basal cell hyperplasia and
positive cuboidal airway lining cells (Figure 2E and F). The immu-
noreactivity of K14 was highly variable, and it was not uncommon to
see low levels or no expression in TG airways. A delicate, granular
pattern was seen in CC10-hK14 TG mice using an antibody cocktail
clone 34bE12 against human high-molecular weight cytokeratins
(supplementary Figure 3s is available at Carcinogenesis Online). In
contrast, most airway lining cells in WT and TG lungs contained
CC10 (Figure 2G and H). Interestingly, there was a 20% reduction
in body weight of TG mice compared with their WT littermates at
14 months (P 5 0.014) (Figure 2I).
In order to measure the expression of the hK14 transgene, lung
tissues derived from CC10-hK14 TG mice were analyzed by
Fig. 2. Characterization of CC10-hK14 TG mice. Photomicrographs of normal bronchiolar epithelium from a WT mouse (A) (hematoxylin and eosin stain;
bar 5 200 lm) and focal epithelial hyperplasia (arrow) from TG mouse (B) (hematoxylin and eosin stain; bar 5 100 lm). Normal bronchiolar epithelium from
a young TG mouse (C) and squamous metaplasia in a TG mouse (D) (hematoxylin and eosin stain; bar 5 400 lm). Inset shows a mitotic ﬁgure and intercellular
bridges. Bronchiolar epithelium from a WT mouse (E) negative for K14 (immunoperoxidase stain; bar 5 200 lm) and K14 immunoreactivity in basal cells (long
arrows) and focal squamous metaplasia (short arrows) in TG bronchiolar epithelium (F) (immunoperoxidase stain; bar 5 100 lm). CC10 immunorectivity in
bronchiolar epithelium from a WT mouse (G) and in hyperplastic, thickened epithelium from a TG mouse (H) (immunoperoxidase stain; bar 5 200 lm).
LU 5 lumen. (I) A graph of body weights. Hatched line 5 WT mice; solid line 5 TG mice; mo 5 months. (J) Expression of hK14 mRNA expression by Q-RT-
PCR with ribosomal S18 as housekeeping gene. Controls included lungs from two lines of WT mice (WT1 and WT2) and BEAS-2B cells (BE). TG tissues
included trachea (TRA) and lungs from independent lines I9, E9, E10 and D1 of mice. M 5 DNA markers. The primers used in this experiment detected only
hK14 genewith a 278 bp product. (K) A bar graph of relative hK14 mRNA expression by Q-RT–PCR in a trachea and lungs from TG lines I9, E9, E10, D1, J7 and
a WT mouse. (L) Immunoprecipitation analysis of hK14 protein in human BEAS-2B cells and WT lung (control) and in lungs from TG mouse lines J7, A9 and E9.
EL H.Dakir et al.
2380semiquantitative and Q-RT–PCR (Figure 2J and K). As expected, no
hK14 messenger RNA (mRNA) was detected in lungs from WT lit-
termates using human-speciﬁc primers (Table I). In lungs from TG
mice, the expression level of hK14 mRNA was comparable with that
found in the positive control of normal human bronchial epithelial
cells BEAS-2B, generating the speciﬁc hK14 band of 278 bp (Figure
2J). By Q-RT–PCR, there was a consistent 4- to 7-fold increase in the
relative expression of hK14 mRNA in lungs of several independent
lines of TG mice (Figure 2K). The hK14 mRNAwas also detected in
the trachea of TG mice.
Moreover, we analyzed the expression of hK14 protein in the
CC10-hK14 TG mouse lungs by immunoprecipitation (Figure 2L).
Strong but variable expression of hK14 was present in the lungs of
several independent lines of TG animals, comparable with the level
seen in the positive control of normal human bronchial epithelial cells
BEAS-2B. As expected, WT lung showed no expression. These ex-
periments conﬁrmed that the transgene hK14 was expressed both at
mRNA and protein level in the lungs of CC10-hK14 mice.
In order to extend our observation that hK14 was expressed in the
trachea of TG animals (Figure 2J and K), we assessed the expression
of K14 in tracheas from several lines of WT and TG mice by semi-
quantitative and Q-RT–PCR and IHC (Figure 3). Using common
primers that have the ability to amplify both human and mouse
K14, we observed a speciﬁc band of K14 with 202 bp size in tracheas
(supplementary Figure 4s is available at Carcinogenesis Online).
Whereas WT mouse tracheas revealed low levels of K14 mRNA
expression, the tracheas from TG mice showed 20–100% increase
in the relative expression of K14 mRNA compared with the ones
obtained from WT mice (Figure 3A). No expression was detected
in WT lung. Immunohistochemical analysis demonstrated multifocal
basal cell hyperplasia as evidenced by continuous rows of K14-
immunoreactive cells and occasional foci of squamous metaplasia
occupying the entire thickness of the epithelial layer (Figure 3B-I).
In contrast, the WT trachea typically revealed only a few, mostly
scattered positive cells (Figure 3B-II).
Evidence for squamous differentiation and increased incidence of
lung tumors in CC10-hK14 mice
A speciﬁc indicator of squamous differentiation is the formation of
CCE (11,12,22). In order to examine whether increased expression
of hK14 was able to induce squamous differentiation in the respiratory
tract of TG mice, we used Q-RT–PCR to measure CCE precursor
proteins involucrin, loricrin, small proline-rich protein 1A and the
enzymes cholesterol sulfotransferase 2B1 as well as transglutaminase
1 that mediates the CCE formation (23–27) (Figure 4). Although the
levels were variable, ﬁve of ﬁve TG mice revealed up to 5-fold in-
crease in involucrin, loricrin and small proline-rich protein 1A
mRNAs in their lungs, and four of ﬁve TG mice up to 2- to 2.5-fold
increase in cholesterol sulfotransferase 2B1 and transglutaminase 1
mRNAs. WT mouse lungs remained negative. The results indicated
that squamous differentiation program was initiated.
In order to investigate whether the constitutive expression of hK14
would induce lung tumors, groups of mice were serially killed and
their lungs were examined. As in many mouse strains, older mice tend
to develop more lung tumors (28), we followed the TG mice until 21
months of age (supplementary Table Is is available at Carcinogenesis
Online). At 6–8 months, ,10% of CC10-hK14 TG mice developed
lung tumors, which was no different than in WT mice. Twenty and
67% (8 of 12) of TG mice had lung tumors at 14 and 21 months,
respectively. In contrast, 27% and only 46% (11 of 24) WT mice had
lung tumors at 14 and 21 months, respectively. Furthermore, detailed
necropsies of four TG mice at the age of 21 months revealed inciden-
tal other tumors characteristic of older FVB/N mice including an
adrenal pheochromocytoma and a mammary carcinoma (data not
shown). No metastases were seen. The results suggested increased
lung tumorigenesis in older TG animals.
Histologically, the pulmonary tumors ranged from adenomas to
poorly differentiated carcinomas of the alveolar compartment and
lacked overt squamous maturation (Figure 5A–D). However, by
IHC focal positivity for the squamous markers p63 and K14
was detected in the airways and 2 of 10 tumors from TG mice,
Fig. 3. Increased expression of K14 and basal cell hyperplasia in TG trachea. (A) Relative expression of K14 mRNA by Q-RT–PCR in the lung and tracheas from
WT littermates of mouse lines D1-1, D1-2 and J7-1 and from TG animals of mouse lines F8-1, D10-1 and D1-3. The primers used in this experiment detected both
mouse and human K14 mRNA. Ribosomal S15 and S18 were used as housekeeping genes. Photomicrographs of (B) basal cell hyperplasia (arrows) in tracheal
epithelium from a TG mouse (I) and scattered basal cells (arrows) in the trachea of a WT mouse (K14 immunoperoxidase stain; bar 5 200 lm). Lu 5 lumen.
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2381whereas the lungs of WT mice were negative (Figure 5E–J, O and P).
Not surprisingly, all tumors were positive for alveolar type II cells
(proSP-C), whereas only selective tumors of TG mice were immuno-
reactive for CC10 (Figure 5K–N). Involucrinwas positive in most WT
and TG tumors, whereas loricrin immunoreactivity was limited to
tumor cells of TG mice (Figure 5Q and R).
Discussion
We hypothesized that mice rarely get pulmonary SQCAs because they
do not express K14 and have rare if any K14-containing cells in the
airways. We showed that expression of hK14 in the airway epithelium
initiates squamous differentiation program and induces a number of
airway abnormalities that greatly mimic premalignant changes of
human lung carcinogenesis.
We used a mCC10 promoter in order to direct the expression of
hK14 to Clara cells that are the progenitor cells of normal and neo-
plastic pulmonary epithelium (29–31) because mouse promoters
allow the gene expression in a speciﬁc, single cell type in mouse lungs
(32–35). Multiple lines of the CC10-hK14 TG mice revealed a 4- to
7-fold relative increase in the mRNA of hK14. Moreover, the protein
levels of K14 were comparable with the levels observed in human
bronchial epithelial cells, which were used as a positive control.
The constitutive expression of hK14 under the mCC10 promoter
was well tolerated in the airways that normally express K8 and K18 of
simple epithelium. The type II keratin K5 mRNA, which is normally
thepartnerforthetypeIkeratinK14,wasslightlydownregulated(data
not shown). However, the expression of K5 was strong in the basal
cells and squamous metaplasias of TG mice that also expressed high
levels of K14providingthe preferred and conceivably stabilizing part-
ner (data not shown) (36,37). Our results are in accordance with pre-
vious studies in which simple epithelial cells transfected with either
an ectopic type I (K14) or type II (K6) epidermal keratin. The foreign
proteins were merely incorporated into the existing endogenous ker-
atin network without induction of partner or host keratins (38).
The strongest functional evidence that constitutive expression of
hK14 in the lung may have an impact on squamous pathway of dif-
ferentiation came from the induction of involucrin, loricrin and other
markers of CCE in the CC10-hK14 TG mice. In the epidermis, the
plasma membrane of terminally differentiated, dead keratinocytes is
replaced by insoluble cross-linked proteins and lipids called the CCE
(11,12), whereas in the human lung cancer cells CCE formation can
be induced in vitro by calcium ions serving as evidence for squamous
differentiation pathway (22).
The molecular changes in CC10-hK14 TG mice were accompanied
by histological changes that were distributed from trachea to periph-
eral airways. This is consistent with the fact that unlike in humans,
where Clara cells are restricted to the peripheral lung, mice have
abundant CC10-containing cells also in trachea (39). One of the alter-
ations was multifocal Clara cell hyperplasia, suggesting that hK14
elicited a proliferative response. Other abnormalities were basal cell
hyperplasia and squamous metaplasia/dyplasia, which are common
early lesions in human squamous cell carcinogenesis (9) but rare in
WT mouse lungs. The origin of basal cells in the murine lung is
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Fig. 4. Expressionof CCEprecursormRNAsin the lungsand tracheaofTGmice.Relative expressionofinvolucrin,loricrin,transglutaminase 1 (TGase1), small-
proline rich protein 1A (SPRR 1A) and cholesterol sulfotransferase 2B1 (SULT2B1) mRNAs was analyzed by Q-RT–PCR in the lung tissue of WT mouse and in
the trachea (TRA) and lungs from CC10-hK14 TG mouse lines I9, E9, E10, D1 and J7. Ribosomal S15 and S18 were used as housekeeping genes.
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Studies on injury and vitamin A deﬁciency have suggested that se-
cretory or Clara cells are pivotal for the regeneration of basal cells of
tracheobronchial epithelium (40–42). We speculate that the expres-
sion of hK14 under the mCC10 promoter might have targeted a com-
mon embryonal precursor cell, which then gave rise both to
presecretory (pre-Clara cells) and prebasal cells by the end of the
pseudoglandular period in the embryonic lung (43,44). In addition
to Clara cells, hK14 transgene may have triggered a proliferative
response also in basal cells.
Despite the proliferative phenotype in the airways of TG mice, the
expression of hK14 had limited impact on tumorigenesis, which re-
quires the accumulation of multiple genetic and epigenetic changes
probably to occur with the increasing age (28). While the number of
animals was too small to reach a deﬁnite conclusion, 67% of the CC10-
hK14 mice had lung tumors at 21 months of age in comparison with
46%of WTmice.The tumorincidencecited inthe literaturefor old(24
months) FVB mice is even lower (38%). Taken together, this data may
warrant further examination of the role of hK14 in tumorigenesis (28).
Histologically, the tumors ranged from adenomas to poorly differenti-
ated carcinomas that might have been expected as the expression of
K14 in the TG lungs was not associated with overt keratinization. On
the other hand, the impact of hK14 manifested in the simultaneous
expression of diverse markers such as the alveolar type II cell marker
proSP-C, airway secretory (Clara) cell marker CC10, epidermal K14
and CCE proteins, suggesting multidirectional differentiation.
There are few previously reported mouse models of lung SQCAs.
In one study, eight different inbred mouse strains were exposed to
N-nitroso-tris-chloroethylurea by skin painting and ﬁve developed
both SQCAs and characteristic precursor lesions that were positive
for the epidermal keratins K5/6 (45). Wang et al. also conducted
linkage analyses and found speciﬁc loci that were associated with
susceptibility to SQCA. There were marked differences between the
strains in the ability to develop SQCAs. Interestingly, as with the
tendency to form pulmonary adenomas, FVB mice were in the middle
of the spectrum and developed low multiplicity of tumors that corre-
lated with less frequent precursor lesions as well. It would be inter-
esting to see if the constitutive expression of hK14 in a more
susceptible strain would result in more pronounced squamous meta-
plasias than the ones observed in the present study utilizing FVB
mice. In another study, a somatically activatable mutant Kras-driven
model of mouse lung cancer was used to evaluate the role of LKB1
and other tumor suppressors in lung carcinogenesis (46). Inactivation
of LKB1 resulted in aggressive and highly metastatic tumors, 60% of
Fig. 5. Tumor histology and immunohistochemical analysis of differentiation in the lungs from CC10-hK14 TG mice. (A) Photomicrograph of a normal airway
from a WT mice (hematoxylin and eosin stain; bar 5 200 lm). (B) An adenoma adjacent to a bronchiolus with mild hyperplasia and atypia from a TG mouse
(hematoxylin and eosin stain; bar 5 400 lm). (C) Histology of a spontaneous adenoma in the lung of a 48-week-old WT mouse (hematoxylin and eosin stain;
bar 5 400 lm). (D) A poorly differentiated spontaneous carcinoma with marked atypia, increased nuclear:cytoplasmic ratio (arrows) and prominent nucleoli in
tumor cells from a TG mouse (hematoxylin and eosin stain; bar 5 400 lm). Panels (E–R) show immunoperoxidase stain as follows: bronchiolar epithelium of
a WT mouse negative for p63 (E) and K14 (F) (bar 5 200 lm). Bronchiolar epithelium from a TG mouse positive for p63 (G) and K14 (H) in basal cells (arrows;
bar 5 200 lm). (I) A spontaneous tumor from a WT mouse negative for K14 (bar 5 200 lm). (J) Scattered K14-positive tumor cells in a TG mouse (arrows;
bar 5 400 lm). (K) A tumor from WT lung negative for CC10 (bar 5 200 lm). (L) A tumor with intense CC10 immunoreactivity (white arrows) from a TG
mouse. The epithelial cells lining an airway lumen (LU) are also positive (bar 5 200 lm). (M) Characteristic immunoreactivity for proSP-C (arrows) in
a pulmonary adenoma from a WT mouse (bar 5 200 lm). (N) The same tumor as in (L) from a TG mouse is also positive for proSP-C (arrows), whereas the cells
lining an airway lumen (LU) are negative(stain; bar 5 200 lm). (O) A tumor from a WT mouse negative for p63 (bar 5 200 lm). (P) Focal immunoreactivity for
p63 (arrows) in a tumor from a TG mouse (bar 5 200 lm). (Q) A tumor (TU) from a WT mouse negative for loricrin (bar 5 200 lm). (R) A tumor from a TG
mouse with strong immunoreactivity for loricrin (bar 5 200 lm).
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2383which revealed squamous or mixed squamous histology although
there was no evidence of squamous precursor lesions in the airways.
In contrast, our results suggest that the constitutive expression of
hK14 is only weakly oncogenic.
In conclusion, constitutive expression of hK14 in the lung resulted
inincreased expression ofK14 and squamous differentiation program.
The mice demonstrated multifocal alterations in the airways ranging
from hyperplasias to squamous metaplasia that were reminiscent of
precursor lesions of human pulmonary SQCA.
Supplementary material
Supplementary Figures 1s–4s and Table Is can be found at http://
carcin.oxfordjournals.org/
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